A research group at Dokkyo Medical University School of Medicine and others conducted a double-blind, crossover study to evaluate the effects of NKCP on blood pressure in patients with lifestyle-related diseases. This study was published in “Journal of Hypertension: Open Access (2014 3:1).”

Hypertension is a risk factor for cardiovascular and cerebrovascular disease and is also involved in atherosclerosis and thrombosis. It has recently been a serious global health issue and effects one in 5.6 persons in Japan.

In this study, NKCP and other supplements derived from natto were administered to 21 patients with lifestyle-related diseases, to evaluate their effects on blood pressure. The patients’ health conditions included hypertension, hyperlipidemia and diabetes. The results showed significant hypotensive effects in the NKCP treatment group, which was attributed to an improvement in blood fluidity by NKCP.

Ongoing research is expected to reveal further wide-range functions for NKCP.